Related Experiment Video
Updated: Oct 3, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Depressive symptoms reduce when dorsolateral prefrontal cortex-precuneus connectivity normalizes after functional
Jessica Elizabeth Taylor1, Takashi Yamada1,2,3, Takahiko Kawashima4
1Department of Decoded Neurofeedback (DecNef), Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International (ATR), Hikaridai 2-2-2. Seika-cho, Soraku, Kyoto, 619-0237, Japan.
This study shows that fMRI functional connectivity neurofeedback can reduce depressive and brooding symptoms by normalizing brain connectivity. This novel approach offers a promising, personalized treatment for specific symptom subsets, with lasting effects observed.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Depressive disorders represent a significant global health burden, often treated uniformly despite symptom heterogeneity.
- Heterogeneous symptoms suggest differing neural mechanisms, necessitating personalized treatment approaches.
Purpose of the Study:
- To test the hypothesis that fMRI functional connectivity neurofeedback can precisely target neural circuits to alleviate specific depressive symptoms.
- To investigate the efficacy of normalizing connectivity between the left dorsolateral prefrontal cortex and left precuneus/posterior cingulate cortex.
Main Methods:
- Proof-of-concept study using fMRI functional connectivity neurofeedback.
- Targeted training to restore anticorrelation between the left dorsolateral prefrontal cortex/middle frontal gyrus and left precuneus/posterior cingulate cortex.
- Assessed symptom reduction in relation to normalized neural connectivity.
Main Results:
- Neurofeedback training successfully normalized the targeted brain connectivity (restored anticorrelation).
- Increased normalization of connectivity correlated with significant reductions in depressive and brooding symptoms.
- No significant reduction was observed in unrelated symptoms like trait anxiety.
- Effects persisted for one to two months post-treatment.
Conclusions:
- Preliminary evidence supports the efficacy of fMRI neurofeedback for treating specific depressive symptoms by normalizing neural network connectivity.
- This personalized approach shows potential clinical utility and reproducibility across different experiments.
- Further research with larger sample sizes and robust controls is warranted to confirm these promising findings.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Depression: Overview
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

